IVI and Grid Biosciences partner for Epstein-Barr virus vaccine development for global access

Vaccines |  News | 0 Comment | 16 Sep, 2023

South Korea-based International Vaccine Institute (IVI), an international organisation with a mission to discover, devel...Read more

Clover Biopharma launches quadrivalent influenza vaccine in Mainland China

Vaccines |  News | 0 Comment | 13 Sep, 2023

Clover Biopharmaceuticals has announced the launch of AdimFlu-S (QIS) in mainland China, where it is the only imported q...Read more

Korea-Serbia collaboration to establish vaccine manufacturing facilities

Vaccines |  News | 0 Comment | 08 Sep, 2023

South Korea-based SK bioscience has announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) visit...Read more

Korea to support fill and finish of oral cholera vaccine in Ghana

Vaccines |  News | 0 Comment | 06 Sep, 2023

South Korea-based International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines have signed a Memorandum of Under...Read more

Korea's IVI renews partnership with CEPI to accelerate development of vaccines

Vaccines |  News | 0 Comment | 04 Sep, 2023

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Insti...Read more

Korea's IVI launches typhoid conjugate vaccine campaign in Africa

Vaccines |  News | 0 Comment | 28 Aug, 2023

South Korea-based International Vaccine Institute (IVI), an international organisation with a mission to discover, devel...Read more

Korea's GC Biopharma to produce cholera vaccines jointly with Eubiologics

Vaccines |  News | 0 Comment | 25 Aug, 2023

South Korea-based GC Biopharma has signed a Memorandum of Understanding (MoU) with Eubiologics (also based in South Kore...Read more

New study in Singapore highlights need for refreshed vaccination strategies

Vaccines |  News | 0 Comment | 25 Aug, 2023

Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...Read more

Australia-Korea joint development agreement for needle-free patch delivery of typhoid vaccine

Vaccines |  News | 0 Comment | 29 Aug, 2023

South Korea-based SK bioscience has entered into a collaboration agreement with Vaxxas, an Australian biotechnology comp...Read more

Japan to design universal vaccines targeting tropical infectious diseases

Vaccines |  News | 0 Comment | 21 Aug, 2023

Japan-based Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company,  will c...Read more

Japanese govt injects $115 M to enhance mRNA manufacturing

Vaccines |  News | 0 Comment | 16 Aug, 2023

US-based Arcturus Therapeutics Holdings Inc., has announced that ARCALIS Co., its manufacturing joint venture in Japan t...Read more

First step towards new vaccine for childhood ear infections in Australia

Vaccines |  News | 0 Comment | 09 Aug, 2023

Australia's University of Adelaide researchers have started work on developing a new vaccine that could help ward off pa...Read more

SK bioscience announces equity investment in Novavax to strengthen strategic partnership

Vaccines |  News | 0 Comment | 09 Aug, 2023

South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...Read more

Bio Farma and MSD launch human papillomavirus vaccine in Indonesia

Vaccines |  News | 0 Comment | 04 Aug, 2023

Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...Read more

Japan's Toyo Ink Group invests in US-based VLP Therapeutics to accelerate vaccine development

Vaccines |  News | 0 Comment | 03 Aug, 2023

Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...Read more

Zuellig Pharma and GSK establish vaccine distribution hub in Singapore

Vaccines |  News | 0 Comment | 01 Aug, 2023

Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...Read more

“Making mRNA vaccines in Asia can potentially bring more affordable vaccines to the world”

Vaccines |  Opinion | 0 Comment | 02 Aug, 2023

What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...Read more

Korea's GC Biopharma gets its first-ever approval of quadrivalent flu vaccine in Africa

Vaccines |  News | 0 Comment | 24 Jul, 2023

GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...Read more